PIM kinases are enzymes that promote metastatic growth and spread of cancer cells. Researchers from the University of Turku, Finland, have obtained new information on how the PIM kinases enhance cancer cell motility by regulating the formation of actin fibres in the cytoskeleton. The published results support the development of PIM-targeted therapies to prevent metastasis formation in cancer patients.
- Researchers adapt cell phone camera for SARS-CoV-2 detection
- Mailman School experts contribute to new Lancet report on health and climate change
- Research reveals how airflow inside a car may affect COVID-19 transmission risk
- No strings attached: maximizing wireless charging efficiency with multiple transmitters
- First in nation treatment for chronic subdural hematoma at Los Robles Health System